These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9463282)

  • 1. [The validity of the IPSS questionnaire in a sample of 262 patients with benign prostatic hyperplasia].
    Luján Galán M; Páez Borda A; Martín Osés E; Llanes González L; Berenguer Sánchez A
    Arch Esp Urol; 1997 Oct; 50(8):847-53. PubMed ID: 9463282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of an Arabic version of the International Prostate Symptom Score.
    Hammad FT; Kaya MA
    BJU Int; 2010 May; 105(10):1434-8. PubMed ID: 19863520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Validation of a French adaptation of the international prostatic symptom score].
    Grégoire JP; Moisan J; Labrecque M; Cusan L; Diamond P
    Prog Urol; 1996 Apr; 6(2):240-9. PubMed ID: 8777417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity and reliability of the Modified Manchester Health Questionnaire in assessing patients with fecal incontinence.
    Kwon S; Visco AG; Fitzgerald MP; Ye W; Whitehead WE;
    Dis Colon Rectum; 2005 Feb; 48(2):323-31; discussion 331-4. PubMed ID: 15616750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of the Mandarin version of the International Prostate Symptom Score inventory in assessing lower urinary tract symptoms in a Malaysian population.
    Quek KF; Chua CB; Razack AH; Low WY; Loh CS
    Int J Urol; 2005 Jan; 12(1):39-45. PubMed ID: 15661053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validity and reliability of the Turkish Migraine Disability Assessment (MIDAS) questionnaire.
    Ertaş M; Siva A; Dalkara T; Uzuner N; Dora B; Inan L; Idiman F; Sarica Y; Selçuki D; Sirin H; Oğuzhanoğlu A; Irkeç C; Ozmenoğlu M; Ozbenli T; Oztürk M; Saip S; Neyal M; Zarifoğlu M;
    Headache; 2004 Sep; 44(8):786-93. PubMed ID: 15330825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a new treatment outcome score for men with LUTS.
    Weiss JP; Blaivas JG; Tash Anger JA; Di Blasio CJ; Panagopoulos G; Gerboc J
    Neurourol Urodyn; 2004; 23(2):88-93. PubMed ID: 14983416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quality of life assessment of the male with benign prostate hypertrophy].
    Nekić VC; Tiljak H; Petricek G; Soldo D; Nekić G; Buljan N
    Acta Med Croatica; 2007 Feb; 61(1):49-55. PubMed ID: 17593641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of prostatic symptoms in patients with prostatic benign hyperplasia].
    Salinas Sánchez AS; Hernánez Millán IR; Segura Martín M; Lorenzo Romero JG; López Torres Hidalgo J; Vírseda Rodríguez JA
    Arch Esp Urol; 2000 Apr; 53(3):212-24. PubMed ID: 10851726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Swedish version of a quality of life questionnaire for partners of men with symptoms suggestive of benign prostatic obstruction.
    Marklund-Bau H; Edéll-Gustafsson U; Spångberg A
    Scand J Urol Nephrol; 2008; 42(2):126-31. PubMed ID: 18365923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy.
    Bastyr EJ; Price KL; Bril V;
    Clin Ther; 2005 Aug; 27(8):1278-94. PubMed ID: 16199253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evidence-based medicine and the validation of quality-of-life questionnaires: the Spanish version of the MOS-HIV questionnaire for the evaluation of the quality of life in patients infected by HIV].
    Badía X; Podzamczer D; López-Lavid C; García M
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():103-13. PubMed ID: 10605195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a voice prosthesis questionnaire to assess valved speech and its related issues in patients following total laryngectomy.
    Kazi R; Singh A; De Cordova J; Al-Mutairy A; Clarke P; Nutting C; Rhys-Evans P; Harrington K
    Clin Otolaryngol; 2006 Oct; 31(5):404-10. PubMed ID: 17014450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Italian linguistic validation of the ureteral stent symptoms questionnaire.
    Giannarini G; Keeley FX; Valent F; Milesi C; Mogorovich A; Manassero F; Barbone F; Joshi HB; Timoney AG; Selli C
    J Urol; 2008 Aug; 180(2):624-8. PubMed ID: 18554654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability and validity of the King's Health Questionnaire for lower urinary tract symptoms in both genders.
    Okamura K; Nojiri Y; Osuga Y
    BJU Int; 2009 Jun; 103(12):1673-8. PubMed ID: 19154505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a quality-of-life scale for Chinese patients with benign prostatic hyperplasia.
    Shi J; Sun Z; Cai T; Yang L
    BJU Int; 2004 Oct; 94(6):837-44. PubMed ID: 15476519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of the IPSS questionnaire in surgical patients. International Prostatic Symptom Score].
    Batista-Miranda JE; Regalado Pareja R; Huguet Pérez J; Montlleo Sánchez M; Araño Bertran P
    Actas Urol Esp; 1995 Mar; 19(3):227-33. PubMed ID: 8659280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of the International Prostate Symptom Score bother question with the Benign Prostatic Hyperplasia Impact Index in a clinical practice setting.
    O'Leary MP; Wei JT; Roehrborn CG; Miner M;
    BJU Int; 2008 Jun; 101(12):1531-5. PubMed ID: 18445080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Spanish version of the WOMAC questionnaire for patients with hip or knee osteoarthritis. Western Ontario and McMaster Universities Osteoarthritis Index.
    Escobar A; Quintana JM; Bilbao A; Azkárate J; Güenaga JI
    Clin Rheumatol; 2002 Nov; 21(6):466-71. PubMed ID: 12447629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries.
    Fourcade RO; Théret N; Taïeb C;
    BJU Int; 2008 May; 101(9):1111-8. PubMed ID: 18279447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.